Qulipta (atogepant) has an elimination half-life of approximately 11 hours, meaning half the drug is cleared from your bloodstream roughly every 11 hours. After about 2.5 days (roughly 55 hours), the drug drops below detectable levels for most people. This timeline holds true regardless of whether you take the 10 mg, 30 mg, or 60 mg dose.
How Qulipta Moves Through Your Body
After you swallow a tablet, Qulipta reaches its peak concentration in your blood within 1 to 2 hours. From there, your liver does most of the work breaking it down, primarily using an enzyme called CYP3A4. Eating a high-fat meal slightly reduces absorption (by about 18 to 22%), but not enough to meaningfully change how the drug works or how long it lasts.
Your body eliminates Qulipta mostly through stool, about 81% of a dose exits that way. A small fraction, around 8%, leaves through urine. In a clinical study tracking a radioactive-labeled dose over 14 days, nearly 90% of the drug was recovered between these two routes.
The 2.5-Day Clearance Window
Pharmacologists use a rule of thumb: it takes about five half-lives for a drug to be essentially gone from your system. With Qulipta’s 11-hour half-life, that math works out to roughly 55 hours, or just over two days. Here’s how the levels drop after your last dose:
- 11 hours: 50% remaining
- 22 hours: 25% remaining
- 33 hours: 12.5% remaining
- 44 hours: about 6% remaining
- 55 hours: about 3% remaining, generally considered fully cleared
One useful detail: Qulipta does not accumulate in your body with repeated daily dosing. Studies confirmed there is no significant buildup even at doses well above the recommended maximum. So whether you’ve been taking it for a week or a year, the clearance timeline after your final dose stays the same.
Dose Size Doesn’t Change the Timeline
Qulipta comes in 10 mg, 30 mg, and 60 mg tablets. You might expect a higher dose to linger longer, but that’s not really the case here. The drug follows what’s called dose-proportional pharmacokinetics: a bigger dose produces a proportionally higher peak level, but the rate at which your body clears it stays consistent. The half-life remains approximately 11 hours across all three doses, and even at experimental doses up to 300 mg in clinical trials.
What Can Slow Clearance
Because Qulipta is processed primarily by the liver, anything that affects liver function can change how long the drug hangs around. In people with severe liver impairment, total drug exposure increases by about 38%. Moderate impairment raises it by 15%, and mild impairment by 24%. People with severe liver problems are advised to avoid Qulipta entirely.
Kidney function plays a smaller role since urine is a minor elimination route. Mild or moderate kidney impairment doesn’t significantly change the drug’s behavior. Severe kidney impairment or end-stage renal disease does warrant a lower dose (10 mg), though this is more about managing higher exposure levels than a dramatically longer clearance time.
Medications that strongly inhibit the CYP3A4 liver enzyme can also slow Qulipta’s breakdown. Certain antifungal drugs and some antibiotics fall into this category. If you take one of these alongside Qulipta, the drug may stay in your system at higher concentrations for longer than the typical 2.5-day window. Your prescriber should already account for this when choosing your dose.
Why This Matters Practically
Most people searching for this information are in one of a few situations: switching medications, concerned about side effects lingering after stopping, or wondering about drug interactions during a gap in dosing. The short answer in all cases is that Qulipta clears relatively quickly compared to many preventive migraine treatments. Injectable CGRP antibodies, for comparison, can take weeks to months to fully leave your system. Qulipta’s 2.5-day clearance means that any side effects you’re experiencing, whether constipation, nausea, or fatigue, should fade within a few days of your last dose. It also means there’s a short transition window if you’re moving to a different preventive medication.